Liver Cancer Awareness Month: Understanding the Risks, Symptoms, and Treatment Options

Strategic Insights -

October is Liver Cancer Awareness Month, a time to acknowledge the growing concern of liver cancer globally. According to the American Cancer Society, more than 800,000 people are diagnosed with liver cancer worldwide each year. In the United States, an estimated 42,200 new cases of liver cancer are expected in 2025, with the diagnosis tripling since 1980 and death rates doubling during the same period. Despite these alarming statistics, advancements in cancer research have led to improved treatments, and patients at Karmanos Cancer Institute have access to cutting-edge therapies.

Key Takeaways:

  • The liver is one of the five vital organs essential for human survival, and prevention is key to lowering the risk of liver cancer.
  • Lifestyle choices such as limiting alcohol use, quitting smoking, eating a balanced diet, exercising regularly, maintaining a healthy weight, and getting vaccinated against hepatitis B can all contribute to reducing the risk of liver cancer.
  • Early detection is crucial, especially for individuals with a high risk of developing liver cancer due to cirrhosis, chronic hepatitis B infection, or hereditary hemochromatosis.
  • Symptoms of liver cancer may not appear until the later stages, including a hard lump on the right side, swollen abdomen, bruising or bleeding easily, discomfort in the upper abdomen, jaundice, nausea, vomiting, and weight loss.
  • The Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team (MDT) at Karmanos Cancer Institute employs the latest technology and treatments, including immunotherapy, minimally invasive surgery, advanced radiation therapy, and the TheraBionic P1 device.
  • Karmanos was the first institution to prescribe the FDA-approved TheraBionic P1 device to patients outside clinical trials, offering patients a portable and non-invasive treatment option for advanced hepatocellular carcinoma.
  • The Karmanos Cancer Institute is a leader in transformative cancer care, research, and education, and is recognized by the National Cancer Institute as one of the best cancer centers in the nation.

Statistics:

  • Over 800,000 people are diagnosed with liver cancer worldwide each year (American Cancer Society).
  • 42,200 new cases of liver cancer are estimated to occur in the United States in 2025 (American Cancer Society).
  • The diagnosis of liver cancer has tripled since 1980.
  • Death rates from liver cancer have doubled since 1980.
  • The liver cancer patient population at Karmanos has access to over 50 clinical trials, providing numerous treatment options.

Sources:

  • Karmanos Cancer Institute
  • American Cancer Society
  • U.S. Food and Drug Administration (FDA)
  • McLaren Health Care
  • Wayne State University School of Medicine
  • National Cancer Institute